Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Emmessar Biotech and Nutrition Ltd
Your Vote -
Buy
66.67%
Hold
16.67%
Sell
16.67%
66.67%
6 users have voted
Option Chain
Analyzes market sentiment, predicts Emmessar Biotech and Nutrition Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Emmessar Biotech - Newspaper Add
-
Emmessar Biotech - Results For The Period Ended March 31, 2025
-
Emmessar Biotech - Board Meeting Outcome for Financial Results For The Period Ended March 31, 2025
-
Emmessar Biotech - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Emmessar Biotech - Board Meeting Intimation for Consideration Of Audited Financial Results For The Period Ended March 31, 202
-
Emmessar Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Emmessar Biotech has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Emmessar Biotech - Newspaper Add For Unaudited Financials For Quarter Ended December 31, 2024
-
Emmessar Biotech - Integrated Filing (Financial)
-
Emmessar Biotech - Announcement under Regulation 30 (LODR)-Change in Management
-
Emmessar Biotech - Unaudited Financial Results For The Quarter Ended December 31, 2024
-
Emmessar Biotech - Board Meeting Outcome for For Unaudited Financial Results For The Quarter Ended December 31, 2024
Key fundamentals
Evaluate the intrinsic value of Emmessar Biotech and Nutrition Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 7.708 | 7.5118 | 6.7467 | 6.1689 | 5.7007 |
Liabilities | 7.708 | 7.5118 | 6.7467 | 6.1689 | 5.7007 |
Equity | 4.9961 | 4.9961 | 4.9961 | 4.9961 | 4.9961 |
Gross Profit | -0.9524 | -1.0819 | -0.6902 | -0.8948 | 0.8466 |
Net Profit | 0.3161 | 0.7496 | 0.5038 | 0.4753 | 1.4497 |
Cash From Operating Activities | 0.2238 | 0.6445 | 0.3762 | 2.2698 | 0.4678 |
NPM(%) | 51.75 | 135.01 | 49.43 | 130.25 | 20.73 |
Revenue | 0.6108 | 0.5552 | 1.0192 | 0.3649 | 6.9907 |
Expenses | 1.5632 | 1.6371 | 1.7094 | 1.2598 | 6.1441 |
ROE(%) | 4.1 | 9.72 | 6.53 | 6.16 | 18.8 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Emmessar Biotech and Nutrition Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Nitta Gelatin India Ltd | 778.05 | -0.18 | 41.79 | 31.80 | 910.25 | 0.77 |
Sharda Cropchem Ltd | 546.75 | -0.71 | 20.33 | 316.04 | 35.34 | 0.55 |
Ram Minerals and Chemicals Ltd | 0.49 | 0.00 | 49.00 | 720.88 | -0.09 | 0.00 |
Amines and Plasticizers Ltd | 206.90 | -2.82 | 27.85 | 192.74 | 361.94 | 0.24 |
Company Info
The Company was incorporated in the state of Maharashtra as a Public Limited Company on 17th March 1992 and certificate of commencement of business dt. 20.3.92 was obtained from Registrar of Companies, Maharashtra, Bombay. The Registered office of the Company is situated at Plot No. T-3/2, MIDC Area, P.O. Box No. 39, Taloja - 410 208, Raigad (Dist), Maharashtra. The Company has revalued the land admeasuring 16,126 Sq. meters, in the month of January 1994, since the MIDC rate per Sq. meter had increased to Rs. 550/- from Rs. 200/- at the time of its purchase in the month of October 1992. The value of the land is now recorded at Rs.88,71,300/- instead of Rs. 32,52,400/ - which was the cost price, vide the valuation report of D K Nagarseth & Associates( Approved Valuer No. F-2087) dated 4th, Jan., 1994. MAIN OBJECTS OF THE COMPANY The main objects to be pursued by the Company on its incorporation as stated in its Memorandum of Association are: To formulate, develop, manipulate, process, import, export, buy, sell, or otherwise deal in all Organic and Inorganic chemicals, Fine chemicals, Heavy chemicals, Performance chemicals, Agro-chemicals, all kinds of organic and Inorganic pigments, colour, Dyestuffs and their intermediates, all kinds of Organic and Inorganic acids and alkalies, Drugs, Medicines and their intermediates, Silicon and Phosphorus based chemicals and byproducts thereof and products to be made there from, and all tools of Bio- Technology. SUBSIDIARIES OF THE COMPANY The Company does not have any subsidiaries. 2005 -Emmessar Biotech enters into strategic alliance with Twilight Mercantiles 2007 -Emmessar Biotech has designated E-mail ID for Investor Complaints: investors@ebnl.in 2008 -Emmessar Technologies Private Ltd became Emmessar Technologies Ltd (ETL) -RESQ, an unfailing solution for treating all types of burns from heat & radiation was launched. -Cute N Comely, a premier topical application with protective & therapeutic properties to ensure an optimal & natural skin rejuvenation process was launched. 2009 -Frejomus tablets was launched to help mitigate joint pains that restrict movement for the middle and old aged people. 2010 -Sepecer, a reliable solution for neurological and physiological health for the middle ages and beyond was launched. 2011 -Psoribalm was launched to meet the long standing demand for a harmless & reliable treatment for the most obstinate & dangerous skin disease - Psoriasis. 2016 -Over 30 newly developed products to meet a spectrum of healthcare needs ready to be launched progressively from mid 2016 onwards.
The Company was incorporated in the state of Maharashtra as a Public Limited Company on 17th March 1992 and certificate of commencement of business dt. 20.3.92 was obtained from Registrar of Companies, Maharashtra, Bombay. The Registered office of the Company is situated at Plot No. T-3/2, MIDC Area, P.O. Box No. 39, Taloja - 410 208, Raigad (Dist), Maharashtra. The Company has revalued the land admeasuring 16,126 Sq. meters, in the month of January 1994, since the MIDC rate per Sq. meter had increased to Rs. 550/- from Rs. 200/- at the time of its purchase in the month of October 1992. The value of the land is now recorded at Rs.88,71,300/- instead of Rs. 32,52,400/ - which was the cost price, vide the valuation report of D K Nagarseth & Associates( Approved Valuer No. F-2087) dated 4th, Jan., 1994. MAIN OBJECTS OF THE COMPANY The main objects to be pursued by the Company on its incorporation as stated in its Memorandum of Association are: To formulate, develop, manipulate, process, import, export, buy, sell, or otherwise deal in all Organic and Inorganic chemicals, Fine chemicals, Heavy chemicals, Performance chemicals, Agro-chemicals, all kinds of organic and Inorganic pigments, colour, Dyestuffs and their intermediates, all kinds of Organic and Inorganic acids and alkalies, Drugs, Medicines and their intermediates, Silicon and Phosphorus based chemicals and byproducts thereof and products to be made there from, and all tools of Bio- Technology. SUBSIDIARIES OF THE COMPANY The Company does not have any subsidiaries. 2005 -Emmessar Biotech enters into strategic alliance with Twilight Mercantiles 2007 -Emmessar Biotech has designated E-mail ID for Investor Complaints: investors@ebnl.in 2008 -Emmessar Technologies Private Ltd became Emmessar Technologies Ltd (ETL) -RESQ, an unfailing solution for treating all types of burns from heat & radiation was launched. -Cute N Comely, a premier topical application with protective & therapeutic properties to ensure an optimal & natural skin rejuvenation process was launched. 2009 -Frejomus tablets was launched to help mitigate joint pains that restrict movement for the middle and old aged people. 2010 -Sepecer, a reliable solution for neurological and physiological health for the middle ages and beyond was launched. 2011 -Psoribalm was launched to meet the long standing demand for a harmless & reliable treatment for the most obstinate & dangerous skin disease - Psoriasis. 2016 -Over 30 newly developed products to meet a spectrum of healthcare needs ready to be launched progressively from mid 2016 onwards.
Read More
Parent Organisation
Emmessar Biotech & Nutrition Ltd.
Founded
17/03/1992
Managing Director
Mr.Srinivasa Raghavan Mathurakavi Ayyangar
NSE Symbol
FAQ
The current price of Emmessar Biotech and Nutrition Ltd is
The 52-week high for Emmessar Biotech and Nutrition Ltd is
The market capitalization of Emmessar Biotech and Nutrition Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Emmessar Biotech and Nutrition Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Emmessar Biotech and Nutrition Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Emmessar Biotech and Nutrition Ltd shares.
The CEO of Emmessar Biotech and Nutrition Ltd is Mr.Srinivasa Raghavan Mathurakavi Ayyangar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.